Hi Cuppajoe2,Thanks for the caution and I agree completely. I...

First 25 Last

Share
Profile

Follow
Travis Cloke

984 Posts.

60

27/05/21

16:37

Post #: 53465079
Share

Originally posted by Cuppajoe2: ↑

Hi Travis,

With respect to you and your question,

suggest great caution in making any investing decision based on the opinion of any stock analyst (whether they openly claim to be a fool or not).

It has been my observation over the years that stock analysts are completely unreliable and usually self serving. The patterns play out again and again... a stock is rising and rising, well past it's intrinsic value and that's just the point when the analysts get excited and raise their "target prices". Even though that is potentially a selling opportunity or at least a hold.

Then when you see a stock getting crushed and the value drops precipitously the analysts fall all over themselves to put out a sell rating... just when you should be buying! Why? Because they do not want to "look" bad. It takes confidence to buy in the down times and discipline to hold or sell in the up times - or to write about doing it.

Also they seem at times completely unaware of and uninterested in what makes a business fundamentally sound and strong. You might be better off with a blindfold and a dartboard than listening to analysts...

For me the universe shrinks to the highest quality companies and they become worth buying when their share price falls comfortably below what I think a share should be worth. This seems to be a foreign concept to most analysts. If you think about it... if they were really good at picking stocks they would be managing a portfolio... not writing about it. As it stands they get paid no matter how consistently bad their advice is...

Anyway my 2c...

Expand

Hi Cuppajoe2,

Thanks for the caution and I agree completely. I don't rate stock analysts projections generally.

Not intending to buy at this point. I bought LBL at $0.31 and was just curious but I appreciate the sentiment.

LBL Price at posting: 80.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 25 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 36.0¢		Change 0.000(0.00%)		Mkt cap ! $42.35M

Open	High	Low	Value	Volume
36.0¢	36.0¢	36.0¢	$120.0K	333.4K

Buyers (Bids)

No.	Vol.	Price($)
3	60007	36.0¢

Sellers (Offers)

Price($)	Vol.	No.
36.5¢	56257	4

View Market Depth

No.	Vol.	Price($)
3	60007	0.360
5	55426	0.355
3	11539	0.350
2	31428	0.345
4	18141	0.340

Price($)	Vol.	No.
0.365	56257	4
0.370	7246	1
0.380	75000	2
0.385	60000	2
0.390	43000	1

Last trade - 12.40pm 26/06/2025 (20 minute delay)

LBL (ASX) Chart

Hi Cuppajoe2,Thanks for the caution and I agree completely. I...

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi Cuppajoe2,Thanks for the caution and I agree completely. I...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News